Boss of Open Orphan volunteers for Covid-19 drug trial
Executive chairman of the Irish drug testing firm, Cathal Friel, wants to be part of study which involves being infected by the virus
The head of Open Orphan, the Irish drug trials and testing company, has said he has volunteered to be infected with a dose of Covid-19 as part of a human study into the virus.
Open Orphan’s subsidiary hVIVO won a £40 million (€44 million) contract with the British government last week which will see it conduct what is termed a human challenge trial, that will involve volunteers being given a strain of Covid-19 to study...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Analysis: Homeworking legislation needs careful framing for best results
With the government moving apace to legislate for people working remotely, employers and employees need assurances
Showcase Ireland crafts platform to help designers shine online
The move has increased six-fold the number of makers who are B2B-enabled, as this year’s Irish crafts fair goes virtual
Cycling legend Kelly gives Kickstarter a spin for next project
The much-decorated cyclist, his business partner Barry Meehan and inventor Stephen Farrell aim to raise €50,000 for exercise bike mount IndoorVelo
Nephin director exits over founders’ dispute
The conflict compounds problems for the Mayo-based distillery, which is a year behind schedule in starting whiskey production
